MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41440-022-00890-8

Медицинская библиотека · Hypertension research : official journal of the Japanese Society of Hypertension · 2022

Diuretics versus others for long-term clinical outcomes as first-line antihypertensive medications: analysis of national real-world database.

Kim Hack-Lyoung, Hwang Doyeon, Lee Jun Hyeok, Lee Hae-Young, Ihm Sang-Hyun, Kim Kwang Il, Shin Jinho, Park Sungha, Kim Dae-Hee, Sung Ki-Chul

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Although several large trials that included African American patients with hypertension have demonstrated the superiority of diuretics as an initial monotherapy, its applicability to other ethnicities remains questionable. The purpose of this study was to investigate whether diuretics as first-line antihypertensive medications are superior to other classes of drugs in the Korean population. Using the Korean National Health Insurance Service database, we analyzed 95,201 Korean hypertensive patients without prior history of cardiovascular disease who started a single antihypertensive drug between January 2002 and December 2017. The primary endpoint was a composite of cardiovascular death, myocardial infarction and stroke. Each endpoint was compared among five classes of antihypertensive drugs [diuretics, angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), calcium channel blockers (CCBs), and beta-blockers (BBs)]. In multivariable Cox analysis, diuretics were superior to ACEIs (hazard ratio [HR], 1.58-2.01), inferior to ARBs (HR, 0.37-0.43) and similar to CCBs and BBs for the primary endpoint. Similar findings were obtained for all-cause and cardiovascular mortality and stroke. This result was consistently observed in the longer treatment group and in the propensity score-matched pairs. In Korean hypertensive patients without cardiovascular disease, initiation with diuretics could not be superior to other medications, but rather inferior to ARBs in preventing adverse cardiovascular outcomes. Randomized studies are needed to confirm our results.

Для цитирования: Kim Hack-Lyoung, Hwang Doyeon, Lee Jun Hyeok, Lee Hae-Young, Ihm Sang-Hyun, Kim Kwang Il, Shin Jinho, Park Sungha, Kim Dae-Hee, Sung Ki-Chul. Diuretics versus others for long-term clinical outcomes as first-line antihypertensive medications: analysis of national real-world database.. Hypertension research : official journal of the Japanese Society of Hypertension. 2022. DOI: 10.1038/s41440-022-00890-8.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.